Caripazim, lyophilizate 350 pe 10 ml

Caripazim promotes the breakdown of necrotic tissues, softening of viscous secretions, blood clots.

In addition, when using the drug for the treatment of musculoskeletal disorders with electrophoresis the elasticity of ligaments and cartilage tissue increases, a resorption effect occurs aimed at spinal hernias and so on.

When used externally the active components are not absorbed and do not have a systemic effect on the body.

All the enzymes that are included in this remedy are broken down and biotransformed in the liver.

Indications

The drug is used on third-degree burns to accelerate the detachment of scabs and to free wounds from suppuration and necrotic tissues.

In addition, since some time the drug has been actively used to treat lesions of orthopedic, traumatological, neurosurgical and neurological nature with electrophoresis, for example:

Composition

Active components:

Papain,

Chymopapain A,

Chymopapain B,

Peptidase A,

Peptidase B,

Lysocin.

How to take, the dosage

Caripazim is used topically in the form of 0.5%, 1% or 2% solutions depending on the thickness of the scab.

The solutions are prepared ex tempore with 0.5% novocaine solution or isotonic sodium chloride solution.

A napkin soaked with the drug is applied to the burned surface and covered with a waterproof dressing.

No more than 30% of the total body surface is treated at a time.

The dressing is changed once a day or once every two days while removing the detached necrotic tissues.

The course of treatment is 4 to 12 days.

Interaction

No clinically significant interactions of caripazim with other drugs have been established.

Special Instructions

The drug Caripazim has no adverse effect on the ability to drive and operate machinery.

Contraindications

This product should not be used for any type of injection or if:

Side effects

Allergic reactions.

Overdose

Incidents of overdose have not been described.